Retrospective analysis of low-dose methadone and QTc prolongation in chronic pain patients
Methadone is a synthetic opioid that is widely used for the treatment of chronic pain. The association between methadone treatment and QT interval prolongation or which can lead to torsades de pointes has been confirmed with larger studies on high dose methadone. The aim of this study was to determi...
Saved in:
Published in | Korean journal of anesthesiology Vol. 58; no. 4; pp. 338 - 343 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Society of Anesthesiologists
01.04.2010
Korean Society of Anesthesiologists 대한마취통증의학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2005-6419 2005-7563 2005-7563 |
DOI | 10.4097/kjae.2010.58.4.338 |
Cover
Abstract | Methadone is a synthetic opioid that is widely used for the treatment of chronic pain. The association between methadone treatment and QT interval prolongation or which can lead to torsades de pointes has been confirmed with larger studies on high dose methadone. The aim of this study was to determine the effect of methadone on the QTc interval in patients, whether the daily dose of methadone should be lower than what has been previously investigated.
A total of 130 patients were included, with 90 patients in the methadone group and 40 patients in the control group. For each ECG, heart rate, QT interval and corrected QT (QTc) interval were recorded. The patient demographics, methadone dose and serum level, duration of methadone use and past medical history were collected.
The QTc interval was significantly longer in the treatment group than in the control group (443 +/- 30.0 ms versus 408 +/- 28.0 ms, respectively, P < 0.0001) and more patients in the treatment group had a QTc interval greater than 450 ms (36.7% versus 7.5%, respectively, P = 0.0005). The QTc interval was not associated with methadone dose P = 0.9278), serum level (P = 0.2256) or duration of treatment (P = 0.1822).
This study has shown that methadone use is associated with longer QTc intervals, even among patients with daily doses of less than 80 mg. In this study, no correlation was found between QTc duration and methadone dose, serum levels or duration of use. However, the magnitude of the QTc interval was associated with female gender and the use of antidepressants. |
---|---|
AbstractList | Background: Methadone is a synthetic opioid that is widely used for the treatment of chronic pain. The association between methadone treatment and QT interval prolongation or which can lead to torsades de pointes has been confirmed with larger studies on high dose methadone. The aim of this study was to determine the effect of methadone on the QTc interval in patients, whether the daily dose of methadone should be lower than what has been previously investigated.
Methods: A total of 130 patients were included, with 90 patients in the methadone group and 40 patients in the control group. For each ECG, heart rate, QT interval and corrected QT (QTc) interval were recorded. The patient demographics, methadone dose and serum level, duration of methadone use and past medical history were collected.
Results: The QTc interval was significantly longer in the treatment group than in the control group (443 ± 30.0 ms versus 408 ± 28.0 ms, respectively, P < 0.0001) and more patients in the treatment group had a QTc interval greater than 450 ms (36.7% versus 7.5%, respectively, P = 0.0005). The QTc interval was not associated with methadone dose P = 0.9278), serum level (P = 0.2256) or duration of treatment (P = 0.1822).
Conclusions: This study has shown that methadone use is associated with longer QTc intervals, even among patients with daily doses of less than 80 mg. In this study, no correlation was found between QTc duration and methadone dose, serum levels or duration of use. However, the magnitude of the QTc interval was associated with female gender and the use of antidepressants. KCI Citation Count: 0 BackgroundMethadone is a synthetic opioid that is widely used for the treatment of chronic pain. The association between methadone treatment and QT interval prolongation or which can lead to torsades de pointes has been confirmed with larger studies on high dose methadone. The aim of this study was to determine the effect of methadone on the QTc interval in patients, whether the daily dose of methadone should be lower than what has been previously investigated.MethodsA total of 130 patients were included, with 90 patients in the methadone group and 40 patients in the control group. For each ECG, heart rate, QT interval and corrected QT (QTc) interval were recorded. The patient demographics, methadone dose and serum level, duration of methadone use and past medical history were collected.ResultsThe QTc interval was significantly longer in the treatment group than in the control group (443 ± 30.0 ms versus 408 ± 28.0 ms, respectively, P < 0.0001) and more patients in the treatment group had a QTc interval greater than 450 ms (36.7% versus 7.5%, respectively, P = 0.0005). The QTc interval was not associated with methadone dose P = 0.9278), serum level (P = 0.2256) or duration of treatment (P = 0.1822).ConclusionsThis study has shown that methadone use is associated with longer QTc intervals, even among patients with daily doses of less than 80 mg. In this study, no correlation was found between QTc duration and methadone dose, serum levels or duration of use. However, the magnitude of the QTc interval was associated with female gender and the use of antidepressants. Methadone is a synthetic opioid that is widely used for the treatment of chronic pain. The association between methadone treatment and QT interval prolongation or which can lead to torsades de pointes has been confirmed with larger studies on high dose methadone. The aim of this study was to determine the effect of methadone on the QTc interval in patients, whether the daily dose of methadone should be lower than what has been previously investigated.BACKGROUNDMethadone is a synthetic opioid that is widely used for the treatment of chronic pain. The association between methadone treatment and QT interval prolongation or which can lead to torsades de pointes has been confirmed with larger studies on high dose methadone. The aim of this study was to determine the effect of methadone on the QTc interval in patients, whether the daily dose of methadone should be lower than what has been previously investigated.A total of 130 patients were included, with 90 patients in the methadone group and 40 patients in the control group. For each ECG, heart rate, QT interval and corrected QT (QTc) interval were recorded. The patient demographics, methadone dose and serum level, duration of methadone use and past medical history were collected.METHODSA total of 130 patients were included, with 90 patients in the methadone group and 40 patients in the control group. For each ECG, heart rate, QT interval and corrected QT (QTc) interval were recorded. The patient demographics, methadone dose and serum level, duration of methadone use and past medical history were collected.The QTc interval was significantly longer in the treatment group than in the control group (443 +/- 30.0 ms versus 408 +/- 28.0 ms, respectively, P < 0.0001) and more patients in the treatment group had a QTc interval greater than 450 ms (36.7% versus 7.5%, respectively, P = 0.0005). The QTc interval was not associated with methadone dose P = 0.9278), serum level (P = 0.2256) or duration of treatment (P = 0.1822).RESULTSThe QTc interval was significantly longer in the treatment group than in the control group (443 +/- 30.0 ms versus 408 +/- 28.0 ms, respectively, P < 0.0001) and more patients in the treatment group had a QTc interval greater than 450 ms (36.7% versus 7.5%, respectively, P = 0.0005). The QTc interval was not associated with methadone dose P = 0.9278), serum level (P = 0.2256) or duration of treatment (P = 0.1822).This study has shown that methadone use is associated with longer QTc intervals, even among patients with daily doses of less than 80 mg. In this study, no correlation was found between QTc duration and methadone dose, serum levels or duration of use. However, the magnitude of the QTc interval was associated with female gender and the use of antidepressants.CONCLUSIONSThis study has shown that methadone use is associated with longer QTc intervals, even among patients with daily doses of less than 80 mg. In this study, no correlation was found between QTc duration and methadone dose, serum levels or duration of use. However, the magnitude of the QTc interval was associated with female gender and the use of antidepressants. Methadone is a synthetic opioid that is widely used for the treatment of chronic pain. The association between methadone treatment and QT interval prolongation or which can lead to torsades de pointes has been confirmed with larger studies on high dose methadone. The aim of this study was to determine the effect of methadone on the QTc interval in patients, whether the daily dose of methadone should be lower than what has been previously investigated. A total of 130 patients were included, with 90 patients in the methadone group and 40 patients in the control group. For each ECG, heart rate, QT interval and corrected QT (QTc) interval were recorded. The patient demographics, methadone dose and serum level, duration of methadone use and past medical history were collected. The QTc interval was significantly longer in the treatment group than in the control group (443 +/- 30.0 ms versus 408 +/- 28.0 ms, respectively, P < 0.0001) and more patients in the treatment group had a QTc interval greater than 450 ms (36.7% versus 7.5%, respectively, P = 0.0005). The QTc interval was not associated with methadone dose P = 0.9278), serum level (P = 0.2256) or duration of treatment (P = 0.1822). This study has shown that methadone use is associated with longer QTc intervals, even among patients with daily doses of less than 80 mg. In this study, no correlation was found between QTc duration and methadone dose, serum levels or duration of use. However, the magnitude of the QTc interval was associated with female gender and the use of antidepressants. |
Author | Park, Chan-Hong Huh, Billy |
AuthorAffiliation | 1 Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA 2 Deaprtment of Anesthesiology and Pain Medicine, Daegu Wooridul Hospital, Daegu, Korea |
AuthorAffiliation_xml | – name: 2 Deaprtment of Anesthesiology and Pain Medicine, Daegu Wooridul Hospital, Daegu, Korea – name: 1 Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA |
Author_xml | – sequence: 1 givenname: Billy surname: Huh fullname: Huh, Billy organization: Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA – sequence: 2 givenname: Chan-Hong surname: Park fullname: Park, Chan-Hong organization: Deaprtment of Anesthesiology and Pain Medicine, Daegu Wooridul Hospital, Daegu, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20508789$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001439029$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp9Uk1v1DAQjVARLaV_gAPKDS5ZHDvxxwWpqvhYqRKiWi5crIk92fVu1g52tqj_Hu9HEeWAL-OZefOerXkvizMfPBbF65rMGqLE-80acEZJTls5a2aMyWfFBSWkrUTL2dnpzptanRdXKa1JPowRwumL4pySlkgh1UXx4w6nGNKIZnL3WIKH4SG5VIa-HMKvyoaE5RanFdgsn9u2_LYw5RjDEPwSJhd86XxpVjF4l-uQkzGX0U_pVfG8hyHh1SleFt8_fVzcfKluv36e31zfVqYlZKqo4BQYp1xZwbsWaQsdk71VjaLKEMsawhppubA1BdEIUAKl6iRirWTXEnZZvDvy-tjrjXE6gDvEZdCbqK_vFnMtKGeSZuj8CLUB1nqMbgvx4YA_FEJcaoiTMwNqhgLAMlXXKBvTdaC6DpE0CJRL0pnM9eHINe66LVqTvxxheEL6tOPdKj_pXlMpuGxZJnh7Iojh5w7TpLcuGRwG8Bh2SQvGaqKIUBn55m-pPxqPa8wAeQSYvMsUsdfGTYftZGU36JrovWn03jR6bxrdSt3obJo8Sv8ZfWT_z9BvXuHGpA |
CitedBy_id | crossref_primary_10_5812_rijm_13642 crossref_primary_10_1097_MPH_0000000000001444 crossref_primary_10_1002_jcph_1999 crossref_primary_10_1111_pme_12658 crossref_primary_10_1186_s12916_014_0178_2 crossref_primary_10_1080_10550887_2013_824333 crossref_primary_10_1016_j_jpainsymman_2013_09_021 crossref_primary_10_1111_pme_12795 crossref_primary_10_34172_jsums_702 crossref_primary_10_1080_17581869_2025_2457316 crossref_primary_10_1007_s12012_018_9474_y crossref_primary_10_4137_PMC_S6803 crossref_primary_10_1093_bja_aet412 crossref_primary_10_1111_j_1540_8167_2011_02231_x crossref_primary_10_1016_j_jcrc_2016_03_023 crossref_primary_10_4103_jrpp_jrpp_49_24 crossref_primary_10_1155_2014_341826 crossref_primary_10_1016_j_jpain_2014_01_495 crossref_primary_10_1093_jbcr_irz200 crossref_primary_10_3109_00952990_2013_804525 crossref_primary_10_1007_s12501_012_0006_3 crossref_primary_10_1213_ANE_0000000000006790 crossref_primary_10_1089_jpm_2016_0411 crossref_primary_10_1111_j_1360_0443_2011_03767_x crossref_primary_10_1177_1049909118811904 crossref_primary_10_1517_14656566_2012_682150 crossref_primary_10_1053_j_jvca_2020_12_011 crossref_primary_10_1097_NCI_0b013e318220c504 |
Cites_doi | 10.1056/NEJMra032426 10.1016/j.jpainsymman.2004.06.012 10.1016/S0304-3959(02)00461-X 10.1016/S0002-9149(03)00906-8 10.1001/jama.289.16.2120 10.1016/S0008-6363(02)00846-5 10.1016/S0022-3565(24)29321-6 10.1001/archinte.166.12.1280 10.1159/000081416 10.1124/jpet.102.038240 10.7326/0003-4819-139-2-200307150-00021 10.1592/phco.2005.25.11.1523 10.1111/j.1525-1497.2006.00588.x 10.1002/pds.1112 10.1016/S0002-9149(02)02337-8 10.1111/j.1360-0443.2006.01668.x 10.1016/S0304-3959(03)00205-7 10.7326/0003-4819-137-6-200209170-00010 10.1007/s00134-004-2335-0 10.7326/0003-4819-139-2-200307150-00021-w2 10.1097/01.jcp.0000132347.81455.57 10.1016/j.amjcard.2004.11.055 10.2165/00003088-199937010-00002 |
ContentType | Journal Article |
Copyright | Copyright © The Korean Society of Anesthesiologists, 2010 2010 |
Copyright_xml | – notice: Copyright © The Korean Society of Anesthesiologists, 2010 2010 |
DBID | AAYXX CITATION NPM 7X8 5PM DOA ACYCR |
DOI | 10.4097/kjae.2010.58.4.338 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2005-7563 |
EndPage | 343 |
ExternalDocumentID | oai_kci_go_kr_ARTI_726382 oai_doaj_org_article_3e7aad3911e84cbba9bbee04ea2680bc PMC2876853 20508789 10_4097_kjae_2010_58_4_338 |
Genre | Journal Article |
GroupedDBID | 5-W 53G 8JR 8XY 9ZL AAYXX ABDBF ACUHS ADRAZ ALMA_UNASSIGNED_HOLDINGS CITATION DIK E3Z EBD EF. ESX F5P GROUPED_DOAJ HYE KQ8 M48 O5R O5S OK1 PGMZT RPM TUS NPM 7X8 5PM ABPTK ACYCR HZB |
ID | FETCH-LOGICAL-c500t-2762a36269d76b5e25ab38fd94929c0d340348d67d12a747a97e89b8ee198b503 |
IEDL.DBID | DOA |
ISSN | 2005-6419 2005-7563 |
IngestDate | Tue Nov 21 21:27:32 EST 2023 Wed Aug 27 01:31:20 EDT 2025 Thu Aug 21 14:12:21 EDT 2025 Fri Sep 05 04:18:28 EDT 2025 Thu Apr 03 07:09:51 EDT 2025 Thu Apr 24 23:10:19 EDT 2025 Tue Jul 01 05:40:28 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Opioid QT interval Methadone |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c500t-2762a36269d76b5e25ab38fd94929c0d340348d67d12a747a97e89b8ee198b503 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-000679.2010.58.4.011 |
OpenAccessLink | https://doaj.org/article/3e7aad3911e84cbba9bbee04ea2680bc |
PMID | 20508789 |
PQID | 733109079 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_726382 doaj_primary_oai_doaj_org_article_3e7aad3911e84cbba9bbee04ea2680bc pubmedcentral_primary_oai_pubmedcentral_nih_gov_2876853 proquest_miscellaneous_733109079 pubmed_primary_20508789 crossref_citationtrail_10_4097_kjae_2010_58_4_338 crossref_primary_10_4097_kjae_2010_58_4_338 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-04-01 |
PublicationDateYYYYMMDD | 2010-04-01 |
PublicationDate_xml | – month: 04 year: 2010 text: 2010-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Korean journal of anesthesiology |
PublicationTitleAlternate | Korean J Anesthesiol |
PublicationYear | 2010 |
Publisher | The Korean Society of Anesthesiologists Korean Society of Anesthesiologists 대한마취통증의학회 |
Publisher_xml | – name: The Korean Society of Anesthesiologists – name: Korean Society of Anesthesiologists – name: 대한마취통증의학회 |
References | Martell (10.4097/kjae.2010.58.4.338_ref12) 2005; 95 Bednar (10.4097/kjae.2010.58.4.338_ref23) 2002; 89 (10.4097/kjae.2010.58.4.338_ref1) 1997; 15 Gil (10.4097/kjae.2010.58.4.338_ref7) 2003; 92 Martell (10.4097/kjae.2010.58.4.338_ref13) 2003; 139 Decerf (10.4097/kjae.2010.58.4.338_ref2) 2004; 30 Lamont (10.4097/kjae.2010.58.4.338_ref3) 2006; 21 Walker (10.4097/kjae.2010.58.4.338_ref4) 2003; 103 Ehret (10.4097/kjae.2010.58.4.338_ref11) 2006; 166 Katchman (10.4097/kjae.2010.58.4.338_ref17) 2002; 303 Kornick (10.4097/kjae.2010.58.4.338_ref15) 2003; 105 Redfern (10.4097/kjae.2010.58.4.338_ref21) 2003; 58 Ferreira (10.4097/kjae.2010.58.4.338_ref20) 2001; 299 Pearson (10.4097/kjae.2010.58.4.338_ref16) 2005; 14 Al-Khatib (10.4097/kjae.2010.58.4.338_ref19) 2003; 289 Krantz (10.4097/kjae.2010.58.4.338_ref5) 2002; 137 Tegeder (10.4097/kjae.2010.58.4.338_ref18) 1999; 37 Krantz (10.4097/kjae.2010.58.4.338_ref14) 2005; 25 Maremmani (10.4097/kjae.2010.58.4.338_ref24) 2005; 11 Cruciani (10.4097/kjae.2010.58.4.338_ref9) 2005; 29 Roden (10.4097/kjae.2010.58.4.338_ref22) 2004; 350 Piguet (10.4097/kjae.2010.58.4.338_ref8) 2004; 24 De Bels (10.4097/kjae.2010.58.4.338_ref6) 2003; 139 Peles (10.4097/kjae.2010.58.4.338_ref10) 2007; 102 16801510 - Arch Intern Med. 2006 Jun 26;166(12):1280-7 12859181 - Ann Intern Med. 2003 Jul 15;139(2):E156 12230351 - Ann Intern Med. 2002 Sep 17;137(6):501-4 17026725 - J Gen Intern Med. 2006 Nov;21(11):C9-C12 15185068 - Intensive Care Med. 2004 Aug;30(8):1690-1 12388652 - J Pharmacol Exp Ther. 2002 Nov;303(2):688-94 15918160 - Pharmacoepidemiol Drug Saf. 2005 Nov;14(11):747-53 17222284 - Addiction. 2007 Feb;102(2):289-300 12859171 - Ann Intern Med. 2003 Jul 15;139(2):154-5 12031739 - Am J Cardiol. 2002 Jun 1;89(11):1316-9 14999113 - N Engl J Med. 2004 Mar 4;350(10):1013-22 11561083 - J Pharmacol Exp Ther. 2001 Oct;299(1):220-6 12791438 - Pain. 2003 Jun;103(3):321-4 15857742 - J Pain Symptom Manage. 2005 Apr;29(4):385-91 15232338 - J Clin Psychopharmacol. 2004 Aug;24(4):446-8 16232014 - Pharmacotherapy. 2005 Nov;25(11):1523-9 12709470 - JAMA. 2003 Apr 23-30;289(16):2120-7 12667944 - Cardiovasc Res. 2003 Apr 1;58(1):32-45 15781034 - Am J Cardiol. 2005 Apr 1;95(7):915-8 15608471 - Eur Addict Res. 2005;11(1):44-9 14556883 - Am J Cardiol. 2003 Oct 15;92(8):995-7 10451781 - Clin Pharmacokinet. 1999 Jul;37(1):17-40 14527710 - Pain. 2003 Oct;105(3):499-506 |
References_xml | – volume: 350 start-page: 1013 year: 2004 ident: 10.4097/kjae.2010.58.4.338_ref22 publication-title: N Engl J Med doi: 10.1056/NEJMra032426 – volume: 29 start-page: 385 year: 2005 ident: 10.4097/kjae.2010.58.4.338_ref9 publication-title: J Pain Symptom Manage doi: 10.1016/j.jpainsymman.2004.06.012 – volume: 103 start-page: 321 year: 2003 ident: 10.4097/kjae.2010.58.4.338_ref4 publication-title: Pain doi: 10.1016/S0304-3959(02)00461-X – volume: 92 start-page: 995 year: 2003 ident: 10.4097/kjae.2010.58.4.338_ref7 publication-title: Am J Cardiol doi: 10.1016/S0002-9149(03)00906-8 – volume: 289 start-page: 2120 year: 2003 ident: 10.4097/kjae.2010.58.4.338_ref19 publication-title: JAMA doi: 10.1001/jama.289.16.2120 – volume: 58 start-page: 32 year: 2003 ident: 10.4097/kjae.2010.58.4.338_ref21 publication-title: Cardiovasc Res doi: 10.1016/S0008-6363(02)00846-5 – volume: 299 start-page: 220 year: 2001 ident: 10.4097/kjae.2010.58.4.338_ref20 publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(24)29321-6 – volume: 166 start-page: 1280 year: 2006 ident: 10.4097/kjae.2010.58.4.338_ref11 publication-title: Arch Intern Med doi: 10.1001/archinte.166.12.1280 – volume: 11 start-page: 44 year: 2005 ident: 10.4097/kjae.2010.58.4.338_ref24 publication-title: Eur Addict Res doi: 10.1159/000081416 – volume: 303 start-page: 688 year: 2002 ident: 10.4097/kjae.2010.58.4.338_ref17 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.102.038240 – volume: 139 start-page: 154 year: 2003 ident: 10.4097/kjae.2010.58.4.338_ref13 publication-title: Ann Intern Med doi: 10.7326/0003-4819-139-2-200307150-00021 – volume: 25 start-page: 1523 year: 2005 ident: 10.4097/kjae.2010.58.4.338_ref14 publication-title: Pharmacotherapy doi: 10.1592/phco.2005.25.11.1523 – volume: 21 start-page: C9 year: 2006 ident: 10.4097/kjae.2010.58.4.338_ref3 publication-title: J Gen Intern Med doi: 10.1111/j.1525-1497.2006.00588.x – volume: 14 start-page: 747 year: 2005 ident: 10.4097/kjae.2010.58.4.338_ref16 publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.1112 – volume: 89 start-page: 1316 year: 2002 ident: 10.4097/kjae.2010.58.4.338_ref23 publication-title: Am J Cardiol doi: 10.1016/S0002-9149(02)02337-8 – volume: 102 start-page: 289 year: 2007 ident: 10.4097/kjae.2010.58.4.338_ref10 publication-title: Addiction doi: 10.1111/j.1360-0443.2006.01668.x – volume: 105 start-page: 499 year: 2003 ident: 10.4097/kjae.2010.58.4.338_ref15 publication-title: Pain doi: 10.1016/S0304-3959(03)00205-7 – volume: 137 start-page: 501 year: 2002 ident: 10.4097/kjae.2010.58.4.338_ref5 publication-title: Ann Intern Med doi: 10.7326/0003-4819-137-6-200209170-00010 – volume: 30 start-page: 1690 year: 2004 ident: 10.4097/kjae.2010.58.4.338_ref2 publication-title: Intensive Care Med doi: 10.1007/s00134-004-2335-0 – volume: 139 start-page: E156 year: 2003 ident: 10.4097/kjae.2010.58.4.338_ref6 publication-title: Ann Intern Med doi: 10.7326/0003-4819-139-2-200307150-00021-w2 – volume: 24 start-page: 446 year: 2004 ident: 10.4097/kjae.2010.58.4.338_ref8 publication-title: J Clin Psychopharmacol doi: 10.1097/01.jcp.0000132347.81455.57 – volume: 15 start-page: 1 year: 1997 ident: 10.4097/kjae.2010.58.4.338_ref1 publication-title: NIH Consens Statement Online – volume: 95 start-page: 915 year: 2005 ident: 10.4097/kjae.2010.58.4.338_ref12 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2004.11.055 – volume: 37 start-page: 17 year: 1999 ident: 10.4097/kjae.2010.58.4.338_ref18 publication-title: Clin Pharmacokinet doi: 10.2165/00003088-199937010-00002 – reference: 15918160 - Pharmacoepidemiol Drug Saf. 2005 Nov;14(11):747-53 – reference: 12859181 - Ann Intern Med. 2003 Jul 15;139(2):E156 – reference: 12667944 - Cardiovasc Res. 2003 Apr 1;58(1):32-45 – reference: 12230351 - Ann Intern Med. 2002 Sep 17;137(6):501-4 – reference: 17222284 - Addiction. 2007 Feb;102(2):289-300 – reference: 12031739 - Am J Cardiol. 2002 Jun 1;89(11):1316-9 – reference: 16232014 - Pharmacotherapy. 2005 Nov;25(11):1523-9 – reference: 11561083 - J Pharmacol Exp Ther. 2001 Oct;299(1):220-6 – reference: 15857742 - J Pain Symptom Manage. 2005 Apr;29(4):385-91 – reference: 15185068 - Intensive Care Med. 2004 Aug;30(8):1690-1 – reference: 16801510 - Arch Intern Med. 2006 Jun 26;166(12):1280-7 – reference: 14527710 - Pain. 2003 Oct;105(3):499-506 – reference: 12859171 - Ann Intern Med. 2003 Jul 15;139(2):154-5 – reference: 15608471 - Eur Addict Res. 2005;11(1):44-9 – reference: 12388652 - J Pharmacol Exp Ther. 2002 Nov;303(2):688-94 – reference: 15232338 - J Clin Psychopharmacol. 2004 Aug;24(4):446-8 – reference: 15781034 - Am J Cardiol. 2005 Apr 1;95(7):915-8 – reference: 12709470 - JAMA. 2003 Apr 23-30;289(16):2120-7 – reference: 17026725 - J Gen Intern Med. 2006 Nov;21(11):C9-C12 – reference: 10451781 - Clin Pharmacokinet. 1999 Jul;37(1):17-40 – reference: 14999113 - N Engl J Med. 2004 Mar 4;350(10):1013-22 – reference: 12791438 - Pain. 2003 Jun;103(3):321-4 – reference: 14556883 - Am J Cardiol. 2003 Oct 15;92(8):995-7 |
SSID | ssj0000330062 |
Score | 1.9540086 |
Snippet | Methadone is a synthetic opioid that is widely used for the treatment of chronic pain. The association between methadone treatment and QT interval prolongation... BackgroundMethadone is a synthetic opioid that is widely used for the treatment of chronic pain. The association between methadone treatment and QT interval... Background: Methadone is a synthetic opioid that is widely used for the treatment of chronic pain. The association between methadone treatment and QT interval... |
SourceID | nrf doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 338 |
SubjectTerms | Clinical methadone opioid qt interval 마취과학 |
SummonAdditionalLinks | – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELaW5cIFgXiFl4zEDaW4iZ8nBIjVgrRIoK204mL5Wbqt4iXtCvj3jJ20omjhxClK7CTOjD0znzL-BqHnKjJpaXQ1lxEASnCkNsS4mojIGiqC9aV6w8lHfjyjH87Y2QHaljsaBbi-EtrlelKzfjX58e3nK1jwEL9OMlvTy-W5CUOSFpMTOgHQdQ1dB8_EMxg7GcP9YpkBvJNSY7QQcHI6VcM-mr88Zs9XFUp_8EBdH6-KRv9MqvzNSx3dQjfH8BK_HubDbXQQujvoy-ew6dN2TyU2Iw8JThGv0vfap3XAuZK08anLzR5_OnUY3r1K3bxoDi867AYaXXxh4GSkY13fRbOjd6dvj-uxpkLtGCGbugHjZzIFjfKCWxYaZmwro1cU4iRHfEtJS6Xnwk8bA1DDKBGksjKEqZKWkfYeOuxgMA8Q9r51pLVWOW4p2AVDKLXCcQWTIkobKzTdSk-7kXA8171YaQAeWeI6S1xniWsmNdUg8Qq92N1zMdBt_LP3m6yUXc9MlV0upH6ux5Wn2yCM8S0Y9SCps9Yoa0MgNJiGS2JdhZ6BSvXSLcr9-ThPetlrABTvtWjAQDUVwluFa1h--Z-K6UK6XOtc8pIoIlSF7g_6342mIRD8CgktYm9m7A13v6VbfC0M3wBjOcRRD__H9z1CN4aMh5xt9BgdbvrL8AQCqY19WlbHL-2hHSE priority: 102 providerName: Scholars Portal |
Title | Retrospective analysis of low-dose methadone and QTc prolongation in chronic pain patients |
URI | https://www.ncbi.nlm.nih.gov/pubmed/20508789 https://www.proquest.com/docview/733109079 https://pubmed.ncbi.nlm.nih.gov/PMC2876853 https://doaj.org/article/3e7aad3911e84cbba9bbee04ea2680bc https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001439029 |
Volume | 58 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Korean Journal of Anesthesiology, 2010, 58(4), , pp.338-343 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxQxFA_SUy-i-DVaSwRvMm128n1si6UKFZQWipeQz7ruMlN2t_jv-5LMLrtF9OJlhpkkTPLey_tgXn4Pofc6ceVY8q1QCQKU6ElrifUtkYl3TEYXSvWGyy_i4pp9vuE3W6W-ck5YhQeuhDumUVobKOzJqJh3zmrnYiQs2k4o4nzWvkSTrWCq6GAI00mpJlqgNgWb6HpiJsM7Hc9-2lizurg6Ykc0H07ZskoFvB9sTb9If_I7H6ZPbtmj8yfo8ehI4pO6gKfoUeyfoe_f4moxrE9PYjsijuAh4fnwqw3DMuJcM9qGoc_NAX-98hi-PR_628IjPO2xr4C5-M7Cwwi8unyOrs8_Xp1dtGP1hNZzQlZtB2rOZrAZHaRwPHbcOqpS0Aw8Ik8CZYQyFYQMk85CUGG1jEo7FeNEK8cJfYH2epjMK4RDoJ5Q57QXjoEGsIQxJ73QwP6kXGrQZE0940do8VzhYm4gxMgUN5niJlPccGWYAYo36MNmzF0F1vhr79PMlE3PDIpdXoComFFUzL9EpUHvgKVm5qdlfL7fDma2MBA6fDKyA1XUNQivGW5go-W_J7aPw_3S5OKWIGhSN-hl5f9mNh0BN1cqaJE7krEz3d2WfvqjYHlDwCrAY3r9P9b3Bu3X3IacV3SA9laL-_gWXKaVOyy7A66XTP0GXmQWow |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Retrospective+analysis+of+low-dose+methadone+and+QTc+prolongation+in+chronic+pain+patients&rft.jtitle=Korean+journal+of+anesthesiology&rft.au=Billy+Huh&rft.au=Chan-Hong+Park&rft.date=2010-04-01&rft.pub=Korean+Society+of+Anesthesiologists&rft.issn=2005-6419&rft.eissn=2005-7563&rft.volume=58&rft.issue=4&rft.spage=338&rft.epage=343&rft_id=info:doi/10.4097%2Fkjae.2010.58.4.338&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_3e7aad3911e84cbba9bbee04ea2680bc |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2005-6419&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2005-6419&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2005-6419&client=summon |